alpha-glutamyltryptophan has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Fukumoto, J; Gill, PS; Masood, R; Sharma, S; Smith, DL; Wei, W; Zhu, S | 1 |
1 other study(ies) available for alpha-glutamyltryptophan and Malignant Melanoma
Article | Year |
---|---|
Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Cytoplasmic Granules; Cytotoxicity, Immunologic; Dipeptides; Flow Cytometry; Humans; Interferon-gamma; Interleukin-12; Killer Cells, Natural; Lung Neoplasms; Melanoma; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplasms, Experimental; Perforin; Pore Forming Cytotoxic Proteins; T-Lymphocytes; Tumor Cells, Cultured | 2003 |